ATE138269T1 - Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen - Google Patents

Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen

Info

Publication number
ATE138269T1
ATE138269T1 AT92901348T AT92901348T ATE138269T1 AT E138269 T1 ATE138269 T1 AT E138269T1 AT 92901348 T AT92901348 T AT 92901348T AT 92901348 T AT92901348 T AT 92901348T AT E138269 T1 ATE138269 T1 AT E138269T1
Authority
AT
Austria
Prior art keywords
live vaccine
additional antigen
subpopulation
presentation
production
Prior art date
Application number
AT92901348T
Other languages
English (en)
Inventor
Thomas Meyer
Johannes Pohlner
Frank U Reuss
Zhengxin Yan
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of ATE138269T1 publication Critical patent/ATE138269T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Outerwear In General, And Traditional Japanese Garments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Road Signs Or Road Markings (AREA)
AT92901348T 1990-12-20 1991-12-20 Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen ATE138269T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4041045A DE4041045A1 (de) 1990-12-20 1990-12-20 Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen

Publications (1)

Publication Number Publication Date
ATE138269T1 true ATE138269T1 (de) 1996-06-15

Family

ID=6420942

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92901348T ATE138269T1 (de) 1990-12-20 1991-12-20 Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen

Country Status (9)

Country Link
US (1) US6255097B1 (de)
EP (1) EP0565548B1 (de)
JP (1) JPH06504434A (de)
AT (1) ATE138269T1 (de)
DE (2) DE4041045A1 (de)
DK (1) DK0565548T3 (de)
ES (1) ES2087512T3 (de)
GR (1) GR3020495T3 (de)
WO (1) WO1992011027A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0835928A1 (de) * 1996-10-11 1998-04-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Helicobacter Pylori Lebendimpfstoff
US6797275B1 (en) * 1998-12-04 2004-09-28 The United States Of America As Represented By The Department Of Health And Human Services Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
US7041296B1 (en) * 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337314A (en) * 1979-05-23 1982-06-29 Research Corporation Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease
GB8314645D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Bivalent vaccines
JPS6363381A (ja) * 1986-09-04 1988-03-19 Kokuritsu Yobou Eisei Kenkyusho 組換えワクチニアウイルス
DE4344350C2 (de) * 1993-12-23 1995-09-21 Max Planck Gesellschaft Bakterien zur Herstellung stabiler Fusionsproteine und Verfahren zu deren Nachweis

Also Published As

Publication number Publication date
DE69119785T2 (de) 1996-12-19
EP0565548B1 (de) 1996-05-22
US6255097B1 (en) 2001-07-03
DE4041045A1 (de) 1992-07-02
GR3020495T3 (en) 1996-10-31
JPH06504434A (ja) 1994-05-26
DK0565548T3 (da) 1996-06-17
DE69119785D1 (de) 1996-06-27
WO1992011027A1 (en) 1992-07-09
ES2087512T3 (es) 1996-07-16
EP0565548A1 (de) 1993-10-20

Similar Documents

Publication Publication Date Title
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
DE69233158D1 (de) Gentechnologisch hergestellter stamm für impfstoffe
DK0612250T3 (da) Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener
KR890701125A (ko) 무병원성 미생물 및 이의 용도
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
DK1294893T3 (da) Modifikation af hepatitis B-kerneantigen
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE69535018D1 (de) Papillomavirus vakzine
GEP20084431B (en) Papilloma virus vaccine
DE69431404D1 (de) Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
ATE44765T1 (de) Lebend-impfstoff und verfahren zu dessen herstellung.
DE69132417D1 (de) Impfstoff gegen die Lyme-Krankheit
ATE162550T1 (de) Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
PT586076E (pt) Vacinas de adenovirus recombinantes
ATE138269T1 (de) Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
PT638316E (pt) Vacinas de adenoviros recombinante
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
NO20020615D0 (no) Vaksine
DK0502146T3 (da) Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
RU95104722A (ru) Способ получения антител к коринебактериям дифтерии

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee